Загрузка видео...

Не удалось загрузить видео

Возникла проблема при загрузке этого видео. Это может быть связано с временными проблемами сети или видео может быть недоступно.

На главную

New microscopy technology enables nanoscale imaging of centimetre-scale tissues, making it possible to image the entire expanded mouse brain at cellular and subcellular resolution. #ReviewedPreprint

eLife - the journal

174,637 subscribers

38,026 просмотров • 2 лет назад •via X (Twitter)

Наука и технологии Образование Здоровье и велнес #ReviewedPreprint

Anya Rossi• Live Now

Private livecam show

Комментарии: 0

Нет доступных комментариев

Здесь появятся комментарии из оригинального поста

Похожие видео

$How do you image the large and the small at the same time? We developed new 🔬 technology to image centimeter-scale specimens - including whole mouse brains 🧠 - with diffraction-limited resolution and without sectioning. #mesoscale #imaging 🧵 (1/n)$

How do you image the large and the small at the same time? We developed new 🔬 technology to image centimeter-scale specimens - including whole mouse brains 🧠 - with diffraction-limited resolution and without sectioning. #mesoscale #imaging 🧵 (1/n)

Adam Glaser

149,237 просмотров • 3 лет назад

Researchers have developed a method that enables three-dimensional RNA analysis at cellular resolution in intact mouse brains. The new method can transform our understanding of brain function. Research by Per Uhlén, Shigeaki_Kanatani, et al. Published in Science Magazine.

Researchers have developed a method that enables three-dimensional RNA analysis at cellular resolution in intact mouse brains. The new method can transform our understanding of brain function. Research by Per Uhlén, Shigeaki_Kanatani, et al. Published in Science Magazine.

Karolinska Institutet

60,542 просмотров • 1 год назад

Brain imaging without compromise. ✨🔬 Using technology originally designed for defect detection in electronics manufacturing, the ExA-SPIM microscope is showing scientists the brain as it’s never been seen before. Look into the future of #microscopy at

Brain imaging without compromise. ✨🔬 Using technology originally designed for defect detection in electronics manufacturing, the ExA-SPIM microscope is showing scientists the brain as it’s never been seen before. Look into the future of #microscopy at

allen institute

54,627 просмотров • 3 лет назад

Together with UC Berkeley we are announcing the laser phase plate - a breakthrough in atomic resolution imaging. This is the brightest continuous wave laser in the world, 100 million times the intensity of the surface of the sun. Phase contrast plays an important role in microscopy, but it was thought close to impossible for electron microscopy, where it would require interfering with an electron beam. Holger Mueller and Robert Glaeser proposed exactly this using a standing wave laser. It has taken over 15 years to make this a reality. Biohub partnered with UC Berkeley and Mueller to support this work and to engineer and build the technology. Contrast has been the critical barrier to achieving atomic resolution imaging of the cell. In cryo-electron tomography, a cellular imaging technology that uses electron microscopy, the low contrast makes it impossible to resolve anything but the largest proteins within their cellular context. The laser phase plate removes that barrier. With advances in AI this breakthrough in contrast will start to open up a new frontier in structural biology, that will allow us to see the molecular machines of the cell, and how they assemble into far more complex and dynamic systems, and understand how they work.

Together with UC Berkeley we are announcing the laser phase plate - a breakthrough in atomic resolution imaging. This is the brightest continuous wave laser in the world, 100 million times the intensity of the surface of the sun. Phase contrast plays an important role in microscopy, but it was thought close to impossible for electron microscopy, where it would require interfering with an electron beam. Holger Mueller and Robert Glaeser proposed exactly this using a standing wave laser. It has taken over 15 years to make this a reality. Biohub partnered with UC Berkeley and Mueller to support this work and to engineer and build the technology. Contrast has been the critical barrier to achieving atomic resolution imaging of the cell. In cryo-electron tomography, a cellular imaging technology that uses electron microscopy, the low contrast makes it impossible to resolve anything but the largest proteins within their cellular context. The laser phase plate removes that barrier. With advances in AI this breakthrough in contrast will start to open up a new frontier in structural biology, that will allow us to see the molecular machines of the cell, and how they assemble into far more complex and dynamic systems, and understand how they work.

Alex Rives

660,496 просмотров • 2 месяцев назад

Long-term live-cell super-res microscopy! 👉🏻our new preprint ( reports >6h STED imaging of ER dynamics in live cells with seconds time resolution. It combines low-light imaging and NN-assisted denoising🔬

Long-term live-cell super-res microscopy! 👉🏻our new preprint ( reports >6h STED imaging of ER dynamics in live cells with seconds time resolution. It combines low-light imaging and NN-assisted denoising🔬

HeilemannLab (👉🏻 heilemannlab.bsky.social)

18,635 просмотров • 2 лет назад

🧠 Neuroimaging has transformed our grasp of brain function! 📢 Ultrasound localization microscopy (ULM) is taking brain imaging to a whole new level. It can capture cerebrovascular flow down to micrometer scales, providing incredible insights. 🌟 #openbci #neuro #research

🧠 Neuroimaging has transformed our grasp of brain function! 📢 Ultrasound localization microscopy (ULM) is taking brain imaging to a whole new level. It can capture cerebrovascular flow down to micrometer scales, providing incredible insights. 🌟 #openbci #neuro #research

OpenBCI

66,645 просмотров • 2 лет назад

I am excited to show you these beautiful movies! A great effort together with Petr Strnad at Viventis Microscopy (Part of Leica Microsystems) to design a new #lightsheet for long term high throughput live imaging of large specimens #organoids, #embryoids and entire animals #hydra.

I am excited to show you these beautiful movies! A great effort together with Petr Strnad at Viventis Microscopy (Part of Leica Microsystems) to design a new #lightsheet for long term high throughput live imaging of large specimens #organoids, #embryoids and entire animals #hydra.

Prisca Liberali

46,891 просмотров • 2 лет назад

HiP-CT is a revolutionary imaging technique that reveals the human body in extraordinary detail. Zoom from an entire organ down to cells and blood vessels. Here, exploring the human brain at micron-scale. [📹 Paul Tafforeau]

HiP-CT is a revolutionary imaging technique that reveals the human body in extraordinary detail. Zoom from an entire organ down to cells and blood vessels. Here, exploring the human brain at micron-scale. [📹 Paul Tafforeau]

Massimo

80,176 просмотров • 8 месяцев назад

The fixed large-scale imaging facility at the new #GordieHoweBridge makes it easier for #CBSA officers to detect suspicious materials, helping #KeepCanadiansSafe.

The fixed large-scale imaging facility at the new #GordieHoweBridge makes it easier for #CBSA officers to detect suspicious materials, helping #KeepCanadiansSafe.

Canada Border Services Agency

11,087 просмотров • 28 дней назад

As reported by the BBC, researchers at the Sudha Gopalakrishnan Brain Centre (SGBC) at IIT Madras have developed ANCHOR—the world's most detailed three-dimensional atlas of the human brainstem at cellular resolution. Created using more than 500 tissue sections spanning foetal, childhood and adult brains, the atlas enables seamless navigation from MRI scans to individual neurons. It identifies over 200 clusters of brain cells and nerve pathways, offering an unprecedented view of the brainstem—the region that controls essential functions such as breathing, heartbeat, sleep, movement and wakefulness. Developed over 18 months by a multidisciplinary team, ANCHOR bridges medical imaging with cellular pathology and has the potential to advance research into neurological disorders, including Alzheimer's disease, Parkinson's disease, stroke and sudden infant death syndrome (SIDS). It is freely accessible to researchers worldwide, marking another significant step in advancing neuroscience and interdisciplinary research. Read here: BBC News (World) Office of Principal Scientific Adviser to the GoI IIT Madras kris gopalakrishnan #IITMadras #BrainResearch #Neuroscience #MedicalResearch #HealthcareInnovation

As reported by the BBC, researchers at the Sudha Gopalakrishnan Brain Centre (SGBC) at IIT Madras have developed ANCHOR—the world's most detailed three-dimensional atlas of the human brainstem at cellular resolution. Created using more than 500 tissue sections spanning foetal, childhood and adult brains, the atlas enables seamless navigation from MRI scans to individual neurons. It identifies over 200 clusters of brain cells and nerve pathways, offering an unprecedented view of the brainstem—the region that controls essential functions such as breathing, heartbeat, sleep, movement and wakefulness. Developed over 18 months by a multidisciplinary team, ANCHOR bridges medical imaging with cellular pathology and has the potential to advance research into neurological disorders, including Alzheimer's disease, Parkinson's disease, stroke and sudden infant death syndrome (SIDS). It is freely accessible to researchers worldwide, marking another significant step in advancing neuroscience and interdisciplinary research. Read here: BBC News (World) Office of Principal Scientific Adviser to the GoI IIT Madras kris gopalakrishnan #IITMadras #BrainResearch #Neuroscience #MedicalResearch #HealthcareInnovation

IIT Madras

21,064 просмотров • 1 месяц назад

RedStone Settle enables RWA DeFi. RWAs made it on-chain. But without reliable liquidation flow, they cannot function as collateral. RedStone Settle changes that, making RWA lending possible at scale. Symbiotic is the first to brings this live.

RedStone Settle enables RWA DeFi. RWAs made it on-chain. But without reliable liquidation flow, they cannot function as collateral. RedStone Settle changes that, making RWA lending possible at scale. Symbiotic is the first to brings this live.

RedStone ♦️

56,960 просмотров • 4 месяцев назад

PHOTON COUNTING CT is NOT a better CT It is a NEW imaging modality Photon Counting CT (PCCT) represents a transformative leap in medical imaging, not only as a molecular imaging modality but also as a technology offering ultra-high resolution and functional imaging capabilities. It is fundamentally more than just an enhanced version of traditional CT—PCCT introduces new ways of seeing and understanding the human body, providing critical insights at the molecular, structural, and functional levels. This positions PCCT as a unique imaging modality that requires a fresh approach to technical implementation, operational workflows, and financial planning. Despite the larger upfront investment, PCCT’s ability to drastically reduce downstream healthcare costs makes it a highly valuable investment in the long run. 1. Technical Innovations • Molecular Imaging and Energy Discrimination: Unlike traditional CT, which simply measures the total absorbed energy, PCCT counts individual X-ray photons and differentiates their energy levels. This allows for precise molecular imaging, revealing the composition of tissues and materials at a biochemical level. By distinguishing between different tissue types and contrast agents, PCCT opens up new diagnostic possibilities, such as identifying molecular biomarkers in tumors or distinguishing between stable and unstable plaque in coronary arteries. This capability shifts the focus of imaging from purely anatomical to both anatomical and molecular, offering more comprehensive diagnostic information. • Ultra-High Spatial Resolution: PCCT features significantly smaller detector elements compared to conventional CT scanners, allowing for ultra-high resolution imaging. This means clinicians can visualize fine structures such as microcalcifications in arteries, small lesions in soft tissues, or the intricate architecture of bones. This level of detail was previously unattainable with traditional CT. When combined with molecular imaging, this ultra-high resolution allows for the precise localization and characterization of disease at very early stages, which is essential for early diagnosis and intervention. • Functional Imaging Capabilities: PCCT also excels as a functional imaging modality. By capturing energy-resolved information, PCCT can provide insights into tissue functionality and dynamic physiological processes. For instance, it can detect changes in blood flow, tissue perfusion, and oxygenation without the need for additional contrast agents or scans. This functionality allows for real-time assessment of physiological processes, making it particularly valuable in cardiology, oncology, and neurology for evaluating organ function and monitoring disease progression. • Reduced Noise and Artifact Reduction: Photon-counting technology dramatically reduces electronic noise and imaging artifacts, such as beam hardening, resulting in clearer and more accurate images. The ability to deliver ultra-high resolution images with minimal artifacts improves diagnostic accuracy, reducing the need for repeat scans and ensuring that even subtle abnormalities are detected. 2. Operational Considerations • New Workflow for Molecular, High-Resolution, and Functional Imaging: The integration of molecular, ultra-high resolution, and functional imaging into routine clinical workflows introduces complexity that requires adaptation. Radiologists and technicians need specialized training to interpret and analyze multi-energy datasets that include molecular and functional information. PCCT produces a vast amount of detailed data, requiring clinicians to adopt new imaging protocols and refine their diagnostic approaches to fully leverage its capabilities. • Post-Processing and Data Management: PCCT generates richer, more complex datasets, which necessitates advanced post-processing tools and data management systems. Existing PACS and imaging software may not be equipped to handle such large volumes of data or to process functional and molecular information effectively. This means healthcare institutions must invest in robust IT infrastructure, including upgraded software and storage solutions, as well as provide additional training for staff on new imaging analysis techniques. • Revised Clinical Protocols: The molecular, functional, and ultra-high resolution imaging capabilities of PCCT will likely prompt changes in clinical protocols. For instance, the need for contrast agents may be reduced, simplifying patient preparation and decreasing the risk of adverse reactions. Additionally, the ability to monitor physiological functions in real-time through functional imaging could lead to more dynamic diagnostic procedures, such as assessing the effectiveness of interventions or treatments in real-time. 3. Financial Impact • Higher Initial Investment: PCCT systems are more expensive than traditional CT scanners due to their advanced technology, which includes photon-counting detectors and the computational power required for high-resolution, molecular, and functional imaging. While this upfront cost is significant, it is crucial to view it in the broader context of the downstream benefits and cost reductions that PCCT offers. • Downstream Cost Reductions: Although the initial capital investment is higher, PCCT’s ability to combine molecular, functional, and ultra-high resolution imaging leads to substantial reductions in downstream healthcare costs. Its superior diagnostic accuracy minimizes the need for follow-up tests, repeat scans, or invasive diagnostic procedures, such as diagnostic coronary angiographies. For example, in cardiology, PCCT can precisely differentiate between types of coronary plaque, reducing the need for invasive procedures to assess risk. • Lower Overall Healthcare Expenditures: By enabling earlier, more accurate diagnoses, PCCT can reduce the overall cost of patient care. Early detection of disease, particularly through its molecular and functional imaging capabilities, allows for more targeted treatments, potentially preventing the need for more aggressive and expensive interventions down the line. For instance, early-stage tumor detection via molecular imaging could lead to less invasive treatments, reducing hospital stays and improving patient outcomes, ultimately driving down healthcare costs. • Increased ROI Through Enhanced Patient Outcomes: Over time, the combination of molecular, functional, and ultra-high resolution imaging enhances diagnostic precision, which translates into better patient outcomes. Improved diagnostic accuracy reduces the incidence of unnecessary procedures, minimizes treatment delays, and results in more personalized and effective care. This leads to increased patient satisfaction, better healthcare outcomes, and greater patient throughput—all factors that improve the institution’s return on investment (ROI). • Competitive Advantage and New Revenue Streams: By adopting PCCT, healthcare institutions position themselves at the forefront of advanced imaging technologies. The ability to offer molecular, functional, and ultra-high resolution imaging creates a competitive advantage, attracting more complex and high-value cases. This can boost the institution’s reputation for excellence in diagnostics, leading to increased referrals, new patient populations, and expanded revenue opportunities. Summary Photon Counting CT (PCCT) is not just an evolution of existing CT technology—it is a molecular, ultra-high resolution, and functional imaging modality that fundamentally transforms the diagnostic landscape. Its ability to capture detailed molecular data, visualize minute anatomical structures with ultra-high resolution, and provide real-time functional imaging opens new possibilities for earlier and more precise diagnoses. While the financial investment in PCCT is larger, the reduction in downstream healthcare costs through improved diagnostic accuracy, fewer unnecessary interventions, and earlier disease detection far outweighs the initial expense. For institutions committed to advancing patient care and improving long-term financial outcomes, PCCT is an essential investment in the future of medical imaging. The video attached shows a patient accessing the Hospital for ACS. PCCT can provide ALL the imaging information of the concurrent imaging modalities (CXR, CAG, Echo, CMR) that you see around it... that's a lot! #PhotonCountingCT #MolecularImaging #UltraHighResolution #FunctionalImaging #FutureOfImaging #AdvancedMedicalImaging #EarlyDiseaseDetection #InnovativeCT #CuttingEdgeHealthcare #PrecisionDiagnostics #HealthcareInnovation #MedicalTechnology #CostEffectiveImaging #NextGenCT #PatientCareRevolution

PHOTON COUNTING CT is NOT a better CT It is a NEW imaging modality Photon Counting CT (PCCT) represents a transformative leap in medical imaging, not only as a molecular imaging modality but also as a technology offering ultra-high resolution and functional imaging capabilities. It is fundamentally more than just an enhanced version of traditional CT—PCCT introduces new ways of seeing and understanding the human body, providing critical insights at the molecular, structural, and functional levels. This positions PCCT as a unique imaging modality that requires a fresh approach to technical implementation, operational workflows, and financial planning. Despite the larger upfront investment, PCCT’s ability to drastically reduce downstream healthcare costs makes it a highly valuable investment in the long run. 1. Technical Innovations • Molecular Imaging and Energy Discrimination: Unlike traditional CT, which simply measures the total absorbed energy, PCCT counts individual X-ray photons and differentiates their energy levels. This allows for precise molecular imaging, revealing the composition of tissues and materials at a biochemical level. By distinguishing between different tissue types and contrast agents, PCCT opens up new diagnostic possibilities, such as identifying molecular biomarkers in tumors or distinguishing between stable and unstable plaque in coronary arteries. This capability shifts the focus of imaging from purely anatomical to both anatomical and molecular, offering more comprehensive diagnostic information. • Ultra-High Spatial Resolution: PCCT features significantly smaller detector elements compared to conventional CT scanners, allowing for ultra-high resolution imaging. This means clinicians can visualize fine structures such as microcalcifications in arteries, small lesions in soft tissues, or the intricate architecture of bones. This level of detail was previously unattainable with traditional CT. When combined with molecular imaging, this ultra-high resolution allows for the precise localization and characterization of disease at very early stages, which is essential for early diagnosis and intervention. • Functional Imaging Capabilities: PCCT also excels as a functional imaging modality. By capturing energy-resolved information, PCCT can provide insights into tissue functionality and dynamic physiological processes. For instance, it can detect changes in blood flow, tissue perfusion, and oxygenation without the need for additional contrast agents or scans. This functionality allows for real-time assessment of physiological processes, making it particularly valuable in cardiology, oncology, and neurology for evaluating organ function and monitoring disease progression. • Reduced Noise and Artifact Reduction: Photon-counting technology dramatically reduces electronic noise and imaging artifacts, such as beam hardening, resulting in clearer and more accurate images. The ability to deliver ultra-high resolution images with minimal artifacts improves diagnostic accuracy, reducing the need for repeat scans and ensuring that even subtle abnormalities are detected. 2. Operational Considerations • New Workflow for Molecular, High-Resolution, and Functional Imaging: The integration of molecular, ultra-high resolution, and functional imaging into routine clinical workflows introduces complexity that requires adaptation. Radiologists and technicians need specialized training to interpret and analyze multi-energy datasets that include molecular and functional information. PCCT produces a vast amount of detailed data, requiring clinicians to adopt new imaging protocols and refine their diagnostic approaches to fully leverage its capabilities. • Post-Processing and Data Management: PCCT generates richer, more complex datasets, which necessitates advanced post-processing tools and data management systems. Existing PACS and imaging software may not be equipped to handle such large volumes of data or to process functional and molecular information effectively. This means healthcare institutions must invest in robust IT infrastructure, including upgraded software and storage solutions, as well as provide additional training for staff on new imaging analysis techniques. • Revised Clinical Protocols: The molecular, functional, and ultra-high resolution imaging capabilities of PCCT will likely prompt changes in clinical protocols. For instance, the need for contrast agents may be reduced, simplifying patient preparation and decreasing the risk of adverse reactions. Additionally, the ability to monitor physiological functions in real-time through functional imaging could lead to more dynamic diagnostic procedures, such as assessing the effectiveness of interventions or treatments in real-time. 3. Financial Impact • Higher Initial Investment: PCCT systems are more expensive than traditional CT scanners due to their advanced technology, which includes photon-counting detectors and the computational power required for high-resolution, molecular, and functional imaging. While this upfront cost is significant, it is crucial to view it in the broader context of the downstream benefits and cost reductions that PCCT offers. • Downstream Cost Reductions: Although the initial capital investment is higher, PCCT’s ability to combine molecular, functional, and ultra-high resolution imaging leads to substantial reductions in downstream healthcare costs. Its superior diagnostic accuracy minimizes the need for follow-up tests, repeat scans, or invasive diagnostic procedures, such as diagnostic coronary angiographies. For example, in cardiology, PCCT can precisely differentiate between types of coronary plaque, reducing the need for invasive procedures to assess risk. • Lower Overall Healthcare Expenditures: By enabling earlier, more accurate diagnoses, PCCT can reduce the overall cost of patient care. Early detection of disease, particularly through its molecular and functional imaging capabilities, allows for more targeted treatments, potentially preventing the need for more aggressive and expensive interventions down the line. For instance, early-stage tumor detection via molecular imaging could lead to less invasive treatments, reducing hospital stays and improving patient outcomes, ultimately driving down healthcare costs. • Increased ROI Through Enhanced Patient Outcomes: Over time, the combination of molecular, functional, and ultra-high resolution imaging enhances diagnostic precision, which translates into better patient outcomes. Improved diagnostic accuracy reduces the incidence of unnecessary procedures, minimizes treatment delays, and results in more personalized and effective care. This leads to increased patient satisfaction, better healthcare outcomes, and greater patient throughput—all factors that improve the institution’s return on investment (ROI). • Competitive Advantage and New Revenue Streams: By adopting PCCT, healthcare institutions position themselves at the forefront of advanced imaging technologies. The ability to offer molecular, functional, and ultra-high resolution imaging creates a competitive advantage, attracting more complex and high-value cases. This can boost the institution’s reputation for excellence in diagnostics, leading to increased referrals, new patient populations, and expanded revenue opportunities. Summary Photon Counting CT (PCCT) is not just an evolution of existing CT technology—it is a molecular, ultra-high resolution, and functional imaging modality that fundamentally transforms the diagnostic landscape. Its ability to capture detailed molecular data, visualize minute anatomical structures with ultra-high resolution, and provide real-time functional imaging opens new possibilities for earlier and more precise diagnoses. While the financial investment in PCCT is larger, the reduction in downstream healthcare costs through improved diagnostic accuracy, fewer unnecessary interventions, and earlier disease detection far outweighs the initial expense. For institutions committed to advancing patient care and improving long-term financial outcomes, PCCT is an essential investment in the future of medical imaging. The video attached shows a patient accessing the Hospital for ACS. PCCT can provide ALL the imaging information of the concurrent imaging modalities (CXR, CAG, Echo, CMR) that you see around it... that's a lot! #PhotonCountingCT #MolecularImaging #UltraHighResolution #FunctionalImaging #FutureOfImaging #AdvancedMedicalImaging #EarlyDiseaseDetection #InnovativeCT #CuttingEdgeHealthcare #PrecisionDiagnostics #HealthcareInnovation #MedicalTechnology #CostEffectiveImaging #NextGenCT #PatientCareRevolution

Dr. Filippo Cademartiri

11,849 просмотров • 1 год назад

We’re hiring at Deep Piction 🧠🔬 We are looking for a Scientist – Tissue Clearing & Image Analysis (m/f/d) to join our team in Munich. You will help drive tissue-clearing, light-sheet microscopy, and quantitative 3D imaging projects across internal R&D programs and collaborations with biotechnology and pharmaceutical partners. The role combines hands-on experimental work, project ownership, workflow development, and close collaboration with our AI and image-analysis teams. We’re looking for someone with strong experience in tissue clearing, fluorescence microscopy, light-sheet imaging, and large-scale 3D image analysis. Please apply with one single PDF containing your CV and cover letter to: hr@deeppiction.com Subject: Scientist – Tissue Clearing & Image Analysis (DP-TC-2026-01) Applications will be reviewed on a rolling basis until the position is filled.

We’re hiring at Deep Piction 🧠🔬 We are looking for a Scientist – Tissue Clearing & Image Analysis (m/f/d) to join our team in Munich. You will help drive tissue-clearing, light-sheet microscopy, and quantitative 3D imaging projects across internal R&D programs and collaborations with biotechnology and pharmaceutical partners. The role combines hands-on experimental work, project ownership, workflow development, and close collaboration with our AI and image-analysis teams. We’re looking for someone with strong experience in tissue clearing, fluorescence microscopy, light-sheet imaging, and large-scale 3D image analysis. Please apply with one single PDF containing your CV and cover letter to: [email protected] Subject: Scientist – Tissue Clearing & Image Analysis (DP-TC-2026-01) Applications will be reviewed on a rolling basis until the position is filled.

Ali Max Erturk

10,948 просмотров • 1 месяц назад

🔬🤖Excited to share permittivity tensor imaging (PTI), a label-free computational imaging module for high-resolution 3D imaging of dry mass and 3D orientation of organelles, cells, and tissues! 🧬🧫 Just published in Nature Methods Shout out to Li-Hao Yeh , Talon Chandler, Ivan Ivanov, Janie Byrum, Bryant , Syuan-Ming Guo, Cameron Foltz at Chan Zuckerberg Biohub Network, Peter Kazansky lab ORC Southampton, BruceConklin lab at Gladstone Institutes, and May Han lab at Stanford Medicine. 🧵1/n

🔬🤖Excited to share permittivity tensor imaging (PTI), a label-free computational imaging module for high-resolution 3D imaging of dry mass and 3D orientation of organelles, cells, and tissues! 🧬🧫 Just published in Nature Methods Shout out to Li-Hao Yeh , Talon Chandler, Ivan Ivanov, Janie Byrum, Bryant , Syuan-Ming Guo, Cameron Foltz at Chan Zuckerberg Biohub Network, Peter Kazansky lab ORC Southampton, BruceConklin lab at Gladstone Institutes, and May Han lab at Stanford Medicine. 🧵1/n

Shalin Mehta

16,623 просмотров • 2 лет назад

The #Coreum Mainnet is officially live! Big thank you to the team and our amazing community for making it possible. A new beginning for blockchain technology arises. 🔗: #BuildOnCoreum

The #Coreum Mainnet is officially live! Big thank you to the team and our amazing community for making it possible. A new beginning for blockchain technology arises. 🔗: #BuildOnCoreum

tx Developer Hub

87,992 просмотров • 3 лет назад

Our new and improved running track at the National Stadium has been completed ahead of schedule. It offers the latest performance technology and presents a bold, beautiful image of Jamaica to the world. #BlackGreenGold #Jamaica #DistinctlyJamaican #ProudlyJamaican #Homeland

Our new and improved running track at the National Stadium has been completed ahead of schedule. It offers the latest performance technology and presents a bold, beautiful image of Jamaica to the world. #BlackGreenGold #Jamaica #DistinctlyJamaican #ProudlyJamaican #Homeland

Ministry of Culture, Gender, Entertainment & Sport

20,205 просмотров • 1 год назад

No device like this has ever been built. Midjourney's whole-body scanner prototype captures hundreds of body slices in just 60 seconds — a completely new infrastructure for full-body imaging. Here's the technology that makes it possible →

No device like this has ever been built. Midjourney's whole-body scanner prototype captures hundreds of body slices in just 60 seconds — a completely new infrastructure for full-body imaging. Here's the technology that makes it possible →

Butterfly Network

21,758 просмотров • 2 месяцев назад

RFK Jr: ''If a foreign enemy did this to our country, we'd consider it an act of war…And we are poisoning our children at scale, at a cellular level.''

RFK Jr: ''If a foreign enemy did this to our country, we'd consider it an act of war…And we are poisoning our children at scale, at a cellular level.''

Joe Rogan Podcast News

49,881 просмотров • 2 месяцев назад

Ever wonder why we decide to build a new microscope and how we go about it? For the last lecture this semester of the graduate microscopy class Na, Gokul, and I teach at Cal, I spoke on our developing iSOAR microscope, a swept HILO design with adaptive optics and structured illumination. iSOAR is designed to produce the petabytes of high resolution 5D videos of subcellular dynamics in zebrafish we need to train the multimodal vision models at the heart of our Cell Observatory Initiative. We still have some work to do, but the scopes are coming along nicely. It's an exciting time at the Observatory, so if you're experienced and looking for a job in zebrafish transgenics, ultra-high throughput image processing, or the development of 5D spatiotemporal foundation models for interpreting the insane dynamic complexity of living matter, we'd love to hear from you. (sup@berkeley.edu, betzige@janelia.hhmi.org).

Ever wonder why we decide to build a new microscope and how we go about it? For the last lecture this semester of the graduate microscopy class Na, Gokul, and I teach at Cal, I spoke on our developing iSOAR microscope, a swept HILO design with adaptive optics and structured illumination. iSOAR is designed to produce the petabytes of high resolution 5D videos of subcellular dynamics in zebrafish we need to train the multimodal vision models at the heart of our Cell Observatory Initiative. We still have some work to do, but the scopes are coming along nicely. It's an exciting time at the Observatory, so if you're experienced and looking for a job in zebrafish transgenics, ultra-high throughput image processing, or the development of 5D spatiotemporal foundation models for interpreting the insane dynamic complexity of living matter, we'd love to hear from you. ([email protected], [email protected]).

Eric Betzig

22,053 просмотров • 8 месяцев назад

Today we're sharing new research that brings us one step closer to real-time decoding of image perception from brain activity. Using MEG, this AI system can decode the unfolding of visual representations in the brain with an unprecedented temporal resolution. More details ⬇️

Today we're sharing new research that brings us one step closer to real-time decoding of image perception from brain activity. Using MEG, this AI system can decode the unfolding of visual representations in the brain with an unprecedented temporal resolution. More details ⬇️

AI at Meta

588,729 просмотров • 2 лет назад